Streetbeat News

Stock Prices

MDT

Medtronic plc. (NYSE:MDT) shares are experiencing an uptrend, rising over 2.5% on Monday and approximately 20% over the past two months. The positive momentum follows better-than-expected Q2 results and increased full-year 2024 guidance. Recent FDA approvals for the PulseSelect PFA System and the Percept RC DBS system, along with CE Mark approval for the MiniMed 780G system with Simplera Sync, have contributed to the stock's rise.

Portfolio Pulse from Ryan Gustafson

January 08, 2024 | 8:54 pm

MRNA

Moderna Inc (NASDAQ:MRNA) shares increased after the company presented updates at the JPMorgan Healthcare Conference. Moderna announced progress in its pipeline, with 45 programs and nine in late-stage development. The company is preparing to launch its RSV vaccine and anticipates sales growth in 2025. Moderna reported $6.7 billion in Covid-19 vaccine sales for 2023 and expects $4 billion in sales in 2024. The company has $13 billion in cash and investments and plans to break even in 2026. Upcoming events include financial results on Feb. 22, Vaccines Day on March 27, and R&D Day on Sept. 12. MRNA shares rose 4.19% to $115.76.

Portfolio Pulse from Adam Eckert

January 08, 2024 | 8:53 pm

NKTX

Nkarta, Inc. (NASDAQ:NKTX) stock has surged over 270% in the past month, with an 80.2% increase on the day of reporting. The spike follows an SEC filing where Nkarta updated its corporate presentation with business and strategic updates. The company specializes in developing engineered natural killer (NK) cells for cancer treatment. The trading volume has significantly exceeded the average, with over 41.3 million shares traded compared to the 100-day average of 2.83 million. The stock is also trading above its 50-day moving average, and a high short interest of 17.7% may be contributing to the price movement.

Portfolio Pulse from Erica Kollmann

January 08, 2024 | 8:51 pm

MBLY

Mobileye Global Inc. (NASDAQ:MBLY) shares rose on Monday after announcing production design wins from a major Western automaker for automated driving solutions in 17 vehicle models. The technology will be featured in both internal combustion and electric vehicles, with a rollout expected in 2026. Mobileye's CEO highlighted the milestone in automated driving development. Despite a tough previous week and a sell-off after preliminary 2023 financial results and 2024 guidance, the stock was up 2.95% at $31.39. Raymond James analyst Brian Gesuale maintained an Outperform rating but lowered the price target from $48 to $40.

Portfolio Pulse from Ryan Gustafson

January 08, 2024 | 8:48 pm

CYCC

Cyclacel Pharmaceuticals' stock is trading higher after the company announced it has regained compliance with the Nasdaq minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 8:39 pm

ASLN

ASLAN Pharmaceuticals (ASLN) shares are trading higher despite the company receiving a minimum bid price deficiency notice from Nasdaq. This notice indicates that ASLN's stock price has fallen below the minimum required bid price threshold set by Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 8:34 pm

APH

Amphenol (NYSE:APH) has delivered an average annual return of 18.8% over the past 5 years, outperforming the market by 5.97% annually. A $1000 investment in APH 5 years ago would be worth $2,356.64 today. Amphenol's market cap stands at $56.52 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 8:30 pm

MAR

Marriott Intl (NASDAQ:MAR) has delivered an average annual return of 15.66% over the past 5 years, outperforming the market by 2.83% on an annualized basis. A $100 investment in MAR 5 years ago would be worth $205.75 today. The company's current market capitalization stands at $65.32 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 8:30 pm

BA

Boeing is set to hold an employee town hall on Tuesday, as reported by CNBC. The town hall could address various topics of interest to employees and investors, such as company performance, future plans, and current challenges. Investors will be watching closely for any announcements or insights that could impact the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 8:24 pm

BONEUSD

SHIBUSD

Shiba Inu (CRYPTO: SHIB) has seen a decline of over 10% in the past week amid reduced transaction activity and burn rates. The Shib team is encouraging investors to purchase Shibarium NFTs to increase transactions. A new whale withdrew 546 million SHIB from Binance, and the burn rate has decreased by 91.2% in the last 24 hours. Despite the weekly drop, SHIB is up 1.9% in the past 24 hours.

Portfolio Pulse from Khyathi Dalal

January 08, 2024 | 8:22 pm